Comment by nick__m

If a disease at a certain well defined stage has a 100% fatality rate after 6 months, why would you need a double blind trial if some patients are still alive 1 year after taking your drug ?

The causality is pretty clear and while you might not claim that it double the life expectancy it would IMHO be immoral not to fast track the approval of that drug.